AML-MDS Novel Prognostic Tests Clinical Study

Clinical trial NCT01685619 · COMPLETED

Trial details

NCT number: NCT01685619
Sponsor: Nova Scotia Health Authority
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)

Start date: 2012-10-02
Primary completion: 2018-01-24
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.